BlackRock Advisors’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q4
$25.1M Buy
175,318
+14,572
+9% +$2.09M 0.03% 450
2016
Q3
$19M Buy
160,746
+77,486
+93% +$9.15M 0.02% 534
2016
Q2
$8.82M Sell
83,260
-257,343
-76% -$27.3M 0.01% 860
2016
Q1
$38M Sell
340,603
-1,020,796
-75% -$114M 0.04% 364
2015
Q4
$213M Sell
1,361,399
-71,933
-5% -$11.3M 0.23% 110
2015
Q3
$188M Buy
1,433,332
+3,864
+0.3% +$507K 0.2% 120
2015
Q2
$249M Sell
1,429,468
-216,944
-13% -$37.7M 0.26% 101
2015
Q1
$284M Sell
1,646,412
-33,505
-2% -$5.78M 0.29% 86
2014
Q4
$218M Sell
1,679,917
-88,106
-5% -$11.4M 0.22% 115
2014
Q3
$227M Buy
1,768,023
+580,992
+49% +$74.7M 0.23% 108
2014
Q2
$105M Sell
1,187,031
-457,334
-28% -$40.5M 0.1% 218
2014
Q1
$155M Buy
1,644,365
+51,831
+3% +$4.87M 0.15% 163
2013
Q4
$180M Buy
1,592,534
+27,580
+2% +$3.12M 0.17% 147
2013
Q3
$123M Buy
1,564,954
+147,846
+10% +$11.7M 0.12% 189
2013
Q2
$93.3M Buy
+1,417,108
New +$93.3M 0.1% 216